Myopia control: Seeing beyond efficacy.

IF 1.6 4区 医学 Q3 OPHTHALMOLOGY Optometry and Vision Science Pub Date : 2024-03-01 DOI:10.1097/OPX.0000000000002119
Mark A Bullimore, Monica Jong, Noel A Brennan
{"title":"Myopia control: Seeing beyond efficacy.","authors":"Mark A Bullimore, Monica Jong, Noel A Brennan","doi":"10.1097/OPX.0000000000002119","DOIUrl":null,"url":null,"abstract":"<p><strong>Significance: </strong>The availability of a range of effective myopia control modalities enables the clinician to exercise judgment when discussing the treatment plan with the patient and their parents. This article outlines important considerations beyond efficacy.Clinically meaningful myopia control may be attained with some spectacle lenses, select soft contact lenses, some concentrations of atropine, and overnight orthokeratology. Given that satisfactory efficacy can be achieved with a range of modalities, other factors should be considered when deciding upon the best intervention for a given child. Four key factors-compliance, quality of vision, quality of life, and safety-are discussed in this review. Compliance directly impacts efficacy regardless of the modality and is the most important consideration, as it is influenced by quality of vision and comfort. Daily disposal myopia control contact lenses and overnight orthokeratology are generally associated with high compliance, provide better vision-related quality of life than spectacles, and carry a very low risk when used appropriately. A further benefit of overnight orthokeratology is the elimination of a need for optical correction during the day.</p>","PeriodicalId":19649,"journal":{"name":"Optometry and Vision Science","volume":"101 3","pages":"134-142"},"PeriodicalIF":1.6000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Optometry and Vision Science","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/OPX.0000000000002119","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Significance: The availability of a range of effective myopia control modalities enables the clinician to exercise judgment when discussing the treatment plan with the patient and their parents. This article outlines important considerations beyond efficacy.Clinically meaningful myopia control may be attained with some spectacle lenses, select soft contact lenses, some concentrations of atropine, and overnight orthokeratology. Given that satisfactory efficacy can be achieved with a range of modalities, other factors should be considered when deciding upon the best intervention for a given child. Four key factors-compliance, quality of vision, quality of life, and safety-are discussed in this review. Compliance directly impacts efficacy regardless of the modality and is the most important consideration, as it is influenced by quality of vision and comfort. Daily disposal myopia control contact lenses and overnight orthokeratology are generally associated with high compliance, provide better vision-related quality of life than spectacles, and carry a very low risk when used appropriately. A further benefit of overnight orthokeratology is the elimination of a need for optical correction during the day.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
近视控制:超越疗效。
意义重大:有了一系列有效的近视控制方法,临床医生在与患者及其家长讨论治疗方案时就可以做出判断。本文概述了除疗效以外的重要考虑因素。某些眼镜片、精选软性隐形眼镜、某些浓度的阿托品和隔夜角膜矫形术可达到有临床意义的近视控制效果。鉴于一系列方法都能达到令人满意的疗效,在决定对特定儿童进行最佳干预时,还应考虑其他因素。本综述将讨论四个关键因素--依从性、视力质量、生活质量和安全性。无论采用哪种方式,依从性都会直接影响疗效,也是最重要的考虑因素,因为它受到视力质量和舒适度的影响。日抛型近视控制隐形眼镜和隔夜角膜矫形术的依从性通常很高,与眼镜相比,它们能提供更好的视力相关生活质量,而且如果使用得当,风险很低。隔夜角膜矫形术的另一个好处是,白天无需进行光学矫正。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Optometry and Vision Science
Optometry and Vision Science 医学-眼科学
CiteScore
2.80
自引率
7.10%
发文量
210
审稿时长
3-6 weeks
期刊介绍: Optometry and Vision Science is the monthly peer-reviewed scientific publication of the American Academy of Optometry, publishing original research since 1924. Optometry and Vision Science is an internationally recognized source for education and information on current discoveries in optometry, physiological optics, vision science, and related fields. The journal considers original contributions that advance clinical practice, vision science, and public health. Authors should remember that the journal reaches readers worldwide and their submissions should be relevant and of interest to a broad audience. Topical priorities include, but are not limited to: clinical and laboratory research, evidence-based reviews, contact lenses, ocular growth and refractive error development, eye movements, visual function and perception, biology of the eye and ocular disease, epidemiology and public health, biomedical optics and instrumentation, novel and important clinical observations and treatments, and optometric education.
期刊最新文献
Case report: Acute macular neuroretinopathy post-COVID-19 infection. Exploring cognitive overload in adults with visual impairment: The association between concentration and fatigue. A pilot study of the impact of repeated blink refrainment on ocular surface temperature and the interblink period. Extended release of ciprofloxacin from commercial silicone-hydrogel and conventional hydrogel contact lenses containing vitamin E diffusion barriers. Efficacy comparison of repeated low-level red-light therapy and orthokeratology lenses for myopia control.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1